RE: Risk of Prostate Cancer in Men Treated with 5α-Reductase Inhibitors-A Large Population-Based Prospective Study

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article numberdjy186
Number of pages1
JournalJournal of the National Cancer Institute
Volume111
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Prostatic Neoplasms
Oxidoreductases
Prospective Studies
Population

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{9d8fb1c3da6c48b5a99094a1781557fe,
title = "RE: Risk of Prostate Cancer in Men Treated with 5α-Reductase Inhibitors-A Large Population-Based Prospective Study",
author = "Patrick Walsh",
year = "2019",
month = "7",
day = "1",
doi = "10.1093/jnci/djy186",
language = "English (US)",
volume = "111",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - RE

T2 - Risk of Prostate Cancer in Men Treated with 5α-Reductase Inhibitors-A Large Population-Based Prospective Study

AU - Walsh, Patrick

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85071084098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071084098&partnerID=8YFLogxK

U2 - 10.1093/jnci/djy186

DO - 10.1093/jnci/djy186

M3 - Letter

C2 - 30380081

AN - SCOPUS:85071084098

VL - 111

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 7

M1 - djy186

ER -